75 related articles for article (PubMed ID: 10368668)
1. Cimetidine enhances the antiproliferative effect of 5-fluorouracil on colon carcinoma SW620.
Komatsubara M; Nagata T; Miyauchi S; Kamo N
Anticancer Res; 1999; 19(2A):1153-7. PubMed ID: 10368668
[TBL] [Abstract][Full Text] [Related]
2. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
3. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells.
Uchida H; Shinoura N; Kitayama J; Watanabe T; Nagawa H; Hamada H
J Gene Med; 2003 Apr; 5(4):287-99. PubMed ID: 12692863
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
7. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
Tang XQ; Bi H; Feng JQ; Cao JG
Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
[TBL] [Abstract][Full Text] [Related]
8. Markers of drug resistance in relapsing colon cancer.
Lazaris AC; Kavantzas NG; Zorzos HS; Tsavaris NV; Davaris PS
J Cancer Res Clin Oncol; 2002 Feb; 128(2):114-8. PubMed ID: 11862483
[TBL] [Abstract][Full Text] [Related]
9. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro.
Ratzenboeck IE; Bartl B; Forstner B; Kalipciyan M; Steger GG; Mader RM
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):81-2. PubMed ID: 21176738
[No Abstract] [Full Text] [Related]
11. [Serum factors in cancer patients affecting the antitumor effect of 5-fluorouracil].
Miwa M; Kojima T; Naruse T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1591-4. PubMed ID: 9725053
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
Vilpo J; Koski T; Vilpo L
Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
[TBL] [Abstract][Full Text] [Related]
16. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
17. Gamma-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs.
Kong X; Ge H; Chen L; Liu Z; Yin Z; Li P; Li M
Toxicol In Vitro; 2009 Jun; 23(4):634-9. PubMed ID: 19268700
[TBL] [Abstract][Full Text] [Related]
18. Suicide activation in a 5-fluorouracil resistant colon cancer model in vitro.
Mader RM; Kalipciyan M; Ohana P; Hochberg A; Steger GG
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):69-70. PubMed ID: 21176733
[No Abstract] [Full Text] [Related]
19. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
